share_log
Breakings ·  Aug 14 06:54
Inhibrx Q2 License Fee Revenue USD 100 Thousand
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment